Contact Hours: 0.5

Max CEU Credits: 0.1

Learning Objectives:

On completion of the chapter, the reader will be able to
1. Explain the Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Text Revision criteria necessary for the diagnosis of attention-deficit hyperactivity disorder.
2. Recommend a therapeutic plan, including initial doses, dosage forms, and monitoring parameters, for a patient with attention-deficit hyperactivity disorder.
3. Differentiate between the available pharmacotherapy used for attention-deficit hyperactivity disorder with respect to pharmacology and pharmaceutical formulation.
4. Recommend second-line and/or adjunctive agents that can be effective alternatives in the treatment of attention-deficit hyperactivity disorder when stimulant therapy is less than adequate.
5. Address potential cost-benefit issues associated with pharmacotherapy of attention-deficit hyperactivity disorder.
6. Recommend strategies for minimizing adverse effects of attention-deficit hyperactivity disorder medications.

Faculty:

ACPE No:
014-999-07-055-H04

---

The University of Georgia College of Pharmacy in on probation as an accredited provider of continuing pharmacy education by the Accreditation Council for Pharmacy Education. Next scheduled review for purposes of restoring accreditation or removing accredited provider status: June 2009